This information was published on 2025-08-11T13:46:36 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2574717 (IR 1868001) |
| (220) |
25 Apr 2025
|
| (300) |
US, 08 Nov 2024, 98844270
|
| (511) (510) |
Class 5
Pharmaceutical preparations to treat Prader-Willi syndrome, neurobehavioral diseases, metabolic diseases, endocrine diseases, and diseases characterized by hyperphagia; pharmaceutical preparations for the treatment of orphan diseases. |
| (540) | VYKAT |
| (550) | Word |
| (730) |
Soleno Therapeutics, Inc.
|
Find out more about publications on the About page.